Natural autoantibodies and associated B cells in immunity and autoimmunity

Autoimmunity

Volumn 46, Issue 2, 2013, Pages 138-147

  Mannoor, Kaiissar ^a   Xu, Yang ^b   Chen, Ching ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Central South University   (China)

Author keywords

Autoantibodies; Autoimmunity; B cells; Natural antibodies

Indexed keywords

AUTOANTIBODY; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; PHOSPHORYLCHOLINE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; BIOLOGICAL ACTIVITY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; INNATE IMMUNITY; NONHUMAN; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; IMMUNITY;

EID: 84873673878     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.748753     Document Type: Review

References (142)

1. Guilbert, B., G. Dighiero, and S. Avrameas. 1982. Naturally occuring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J. Immunol 128: 2779-2787
2. Dighiero, G., P. Lymberi, J. C. Mazie, et al. 1983. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J. Immunol 131: 2267-2272
3. Dighiero, G., P. Lymberi, B. Guilbert, T. Ternynck, and S. Avrameas. 1986. Natural autoantibodies constitute a substantial part of normal circulating immunoglobulin. Ann. N.Y. Acad. Sci 475: 135-145
4. Coutinho, A., M. D. Kazatchkine, and S. Avrameas. 1995. Natural autoantibodies. Curr. Opin. Immunol 7: 812-818
5. Avrameas, S. 1991. Natural autoantibodies: from horror autotoxicus to gnothi seauton. Immunol. Today 12: 54
6. Haspel, M. V., T. Onodera, B. S. Prabhakar, et al. 1983. Virus-induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science 220: 304-306
7. Haspel, M. V., T. Onodera, B. S. Prabhakar, et al. 1983. Multiple organ-reactive monoclonal autoantibodies. Nature 304: 73-76
8. Satoh, J., B. S. Prabhakar, M. V. Haspel, F. Ginsberg-Fellner, and A. L. Notkins. 1983. Human monoclonal autoantibodies that react with multiple endocrine organs. N. Engl. J. Med 309: 217-220
9. Casali, P., and A. Notkins. 1989. CD5 B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol. Today 10: 364-368
10. Mouthon, L., A. Nobrega, N. Nicolas, et al. 1995. Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults. Proc. Natl. Acad. Sci. USA 92: 3839-3843
11. Chen, Z. J., C. J. Wheeler, W. Shi, et al. 1998. Polyreactive antigen-binding B cells are the predominant cell type in the newborn B cell repertoire. Eur. J. Immunol 28: 989-994
12. Merbl, Y., M. Zucker-Toledano, F. Quintana, and I. Cohen. 2007. Newborn humans manifest autoantibodies to defined self molecules detected by antigen microarray informatics. J. Clin. Invest 117: 712-718
13. Dighiero, G., P. Lymberi, D. Holmberg, et al. 1985. High frequency of natural autoantibodies in normal newborn mice. J. Immunol 134: 765-771
14. Hooijkaas, H., R. Benner, J. R. Pleasants, and B. S. Wostmann. 1984. Isotypes and specificities of immunoglobulins produced by germ-free mice fed chemically defined ultrafiltered "antigenfree" diet. Eur. J. Immunol 14: 1127-1130
15. Wardemann, H., S. Yurasov, A. Schaefer, et al. 2003. Predominant autoantibody production by early human B cell precursors. Science 301(5638): 1374-1377
16. Gonzalez, R., J. Charlemagne,W. Mahana, and S. Avrameas. 1988. Specificity of natural serum antibodies present in phylogenetically distinct fish species. Immunology 63: 31-36
17. Flajnik, M., and L. Rumfelt. 2000. Early and natural antibodies in non-mammalian vertebrates. Curr. Top. Microbiol. Immunol 252: 233-240
18. Souroujon, M., M. E. White-Scharf, J. Andreschwartz, M. L. Gefter, and R. S. Schwartz. 1988. Preferential autoantibody reactivity of the preimmune B cell repertoire in normal mice. J. Immunol 140: 4173-4179
19. Notkins, A. L. 2004. Polyreactivity of antibody molecules. Trends Immunol. 25: 174-179
20. Chen, C., M. P. Stenzel-Poore, and M. B. Rittenberg. 1991. Natural auto-and polyreactive antibodies differing from antigen-induced antibodies in theHchain CDR3. J. Immunol 147: 2359-2367
21. Poncet, P., T. Matthes, A. Billecocq, and G. Dighiero. 1988. Immunochemical studies of polyspecific natural autoantibodies: charge, lipid reactivity, Fab'2 fragment activity and complement fixation. Mol. Immunol 25: 981
22. Fernandez, P.-A., T. Ternynck, and S. Avrameas. 1989. Immunochemical studies of a murine polyreactive IgG2b autoantibody with rheumatoid factor activity. Mol. Immunol 26: 539
23. Bona, C. A. 1988. V genes encoding autoantibodies: molecular and phenotypic characteristics. Ann. Rev. Immunol 6: 327
24. Baccala, R., T. V. Quang, M. Gilbert, T. Ternynck, and S. Avrameas. 1989. Two murine natural polyreactive autoantibodies are encoded by nonmutated germline genes. Proc. Natl. Acad. Sci. USA 86: 4624
25. Kofler, R., F. J. Dixon, and A. N. Theofilopoulos. 1987. The genetic origin of autoantibodies. Immunol. Today 8: 374
26. Hartman, A. B., C. P. Mallett, J. Srinivasappa, et al. 1989. Organ reactive autoantibodies from non-immunized adult BALB/c mice are polyreactive and express non-biased VH gene usage. Mol. Immunol 26: 359-370
27. Ichiyoshi, Y., and P. Casali. 1994. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med 180: 885-895
28. Ichiyoshi, Y., and P. Casali. 1995. Analysis of the structural correlates for self-antigen binding by natural and diseaserelated autoantibodies. In vitro expression of recombinant and/or mutagenized human IgG. Ann N Y Acad Sci 764: 328-341
29. Casali, P., and E.W. Schettino. 1996. Structure and function of natural antibodies. Curr. Top. Microbiol. Immunol 210: 167-179
30. Martin, T., R. Crouzier, J. C. Weber, T. J. Kipps, and J. L. Pasquali. 1994. Structure-function studies on a polyreactive [natural] autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J. Immunol 152: 5988-5996
31. Deng, Y. J., and A. L. Notkins. 2000. Molecular determinants of polyreactive antibody binding:HCDR3and cyclic peptides. Clin. Exp. Immunol 119: 69-76
32. Amit, A. G., R. A. Mariuzza, S. E. Phillips, and R. J. Poljak. 1986. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science 233: 747-753
33. Segal, D. M., E. A. Padlan, G. H. Cohen, et al. 1974. The three-dimensional structure of a phosphorylcholine-binding mouse immunoglobulin Fab and the nature of the antigen binding site. Proc. Natl. Acad. Sci. USA 71: 4298-4302
34. Martin, F., and J. F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev 175: 7079
35. Hayakawa, K., R. R. Hardy, D. R. Parks, and L. A. Herzenberg. 1983. The "Ly-1" B cell subpopulation in normal, immunodefective, and autoimmune mice. J. Exp. Med 157: 202-218
36. Kantor, A. B., and A. Herzenberg. 1993. Origin of murine B cell lineages. Annu. Rev. Immunol 11: 501-538
37. Baumgarth, N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46
38. Martin, F., and J. F. Kearney. 2000. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 12: 39-49
39. Pennell, C. A., L.W. Arnold,G. Haughton, and S. H. Clarke. 1988. Restricted Ig variable region gene expression among Ly-1 B cell hybridomas. J. Immunol 141: 2788-2796
40. Tarlinton, D., A. M. Stall, and L. A. Herzenberg. 1988. Repetitive usage of immunoglobulin VH and D gene segments in CD5 Ly-1 B clones of [NZB x NZW]F1 mice. EMBO J 7: 3705-3710
41. Tornberg, U. C., and D. Holmberg. 1995. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressure. EMBO J 14: 1680-1689
42. Kantor, A. B., C. E. Merrill, L. A. Herzenberg, and J. L. Hillson. 1997. An unbiased analysis of VH-D-JH sequences from B-1a, B-1b and conventional B cells. J. Immunol 158: 1175-1186
43. Gu, H., I. Forster, and K. Rajewsky. 1990. Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cells and B-CLL progenitor generation. EMBO J 9: 2133
44. Zhou, Z. H., and A. L. Notkins. 2004. Polyreactive antigenbinding B [PAB-] cells are widely distributed and the PAB population consists of both B-1 and B-1-phenotypes. Clin. Exp. Immunol 137: 88-100
45. Thurnheer, M. C., A.W. Zuercher, J. J. Cebra, andN. A. Bos. 2003. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice. J. Immunol 170: 4564-4571
46. Nobrega, A., B. Stransky, N. Nicolas, and A. Coutinho. 2002. Regeneration of natural antibody repertoire after massive ablation of lymphoid system: robust selection mechanisms preserve antigen binding specificities. J. Immunol 169: 2971-2978
47. Tian, Q., M. Beardall, Y. Xu, et al. 2006. B cells expressing a natural polyreactive autoantibody have a distinct phenotype and are overrepresented in immunoglobulin heavy chain transgenic mice. J. Immunol 177: 2412-2422
48. Hayakawa, K., M. Asano, S. A. Shinton, et al. 2003. Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development. J. Exp. Med 197: 87-99
49. Baumgarth,N.,O.C. Herman, G. C. Jager, L. A. Herzenberg, and L. A. Herzenberg. 1999. Innate and acquired immunities to influenza virus are provided by distinct B cells. Proc. Natl. Acad. Sci. USA 96: 2250-2255
50. Ochsenbein, A. F., T. Fehr, and C. Lutz, 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science 286: 2156-2159
51. Baumgarth, N., O. C. Herman, G. C. Jager, et al. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med 192: 271-280
52. Boes, M., A. P. Prodeus, T. Schmidt, M. C. Carroll, and J. Chen. 1998. A critical role of natural immunoglobulinMin immediate defense against systemic bacterial infection. J. Exp. Med 188: 2380-2386
53. Diamond, M. S., E. M. Sitati, L. D. Friend, et al. 2003. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med 198: 1853-1862
54. Rajan, B., T. Ramalingam, and T. V. Rajan. 2005. Critical role for IgM in host protection in experimental filarial infection. J Immunol 175: 1827-1833
55. Zhou, Z. H., Y. Zhang, Y. F. Hu, et al. 2007. The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies. Cell Host Microbe 1: 51-61
56. Jayasekera, J. P., E. A. Moseman, and M. C. Carroll. 2007. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol 81: 3487-3494
57. Rapaka, R. R., D. M. Ricks, J. F. Alcorn, et al. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J. Exp. Med 207: 2907-2919
58. Racine, R., and G. M. Winslow. 2009. IgM in microbial infections: taken for granted? Immunol. Lett 125: 79-85
59. Boes, M. 2000. Role of natural and immune IgM antibodies in immune responses. Mol. Immunol 37: 1141-1149
60. Matejuk, A., M. Beardall, Y. Xu, et al. 2009. Exclusion of natural autoantibody-producing B cells from IgG memory B cell compartment during T cell-dependent immune responses. J. Immunol 182: 7634-7643
61. Chen, C., V. Roberts, and M. Rittenberg. 1992. Generation and analysis of random point mutations in an antibody CDR2 sequence: many mutated antibodies lose their ability to bind antigen. J. Exp. Med 176: 855-866
62. Chen, C., V. Roberts, S. Stevens, et al. 1995. Enhancement and destruction of antibody function by somatic mutation: unequal occurrence is controlled by V gene combinatorial associations. EMBO J 14: 2784-2794
63. Wiens, G., M. Brown, and M. Rittenberg. 2003. Repertoire shift in the humoral response to phosphocholine-keyhole limpet hemocyanin: VH somatic mutation in germinal center B cells impairs T15 Ig function. J. Immunol 170: 5095-5102
64. Chen, C., T. Martin, S. Stevens, and M. Rittenberg. 1994. Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2. J. Exp. Med 180: 577-586
65. Xu, Z., E. J. Pone, A. Al-Qahtani, et al. 2007. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit. Rev. Immunol 27: 367-397
66. McBride, K. M., A. Gazumyan, E. M. Woo, et al. 2008. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med 205: 2585-2594
67. Mannoor, K., A. Matejuk, Y. Xu, M. Beardall, and C. Chen. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival. J. Immunol 188: 3628-3638
68. Qin, X. F., S. Schwers, W. Yu, et al. 1999. Secondary V[D]J recombination in B1 cells. Nature 397: 355-359
69. Yurasov, S., H. Wardemann, J. Hammersen, et al. 2005. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med 201: 703-711
70. Samuels, J., Y. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med 201: 1659-1667
71. Cook, W. D., S. Rudikoff, A. M. Giusti, et al. 1980. Antigen binding variants of the S107 mouse myeloma cell line. Prog. Clin. Biol. Res 42: 217-230
72. Napastek, Y., J. Andre-Schwartz, T. Manser, et al. 1986. A single germline VH gene segment of normal A/J mice encodes autoantibodies characteristic of systemic lupus erythematosus. J. Exp. Med 164: 614-626
73. Ikematsu, H., M. T. Kasaian, E. W. Schettino, and P. Casali. 1993. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J. Immunol 151: 3604-3616
74. Boes, M., C. Esau, M. B. Fischer, et al. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol 160: 4776-4787
75. Ehrenstein, M. R., T. L. O'Keefe, S. L. Davies, and M. S. Neuberger. 1998. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. USA 95: 10089-10093
76. Ehrenstein, M. R., H. T. Cook, and M. S. Neuberger. 2000. Deficiency in serum immunoglobulin [Ig]M predisposes to development of IgG autoantibodies. J. Exp. Med 191: 1253-1258
77. Boes, M., T. Schmidt, K. Linkemann, et al. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl. Acad. Sci. USA 97: 1184-1189
78. Jiang, C., J. Foley, N. Clayton, et al. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol 178: 7422-7431
79. Jiang, C., M. L. Zhao, R. M. Scearce, and M. Diaz. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum 63: 1086-1096
80. Werwitzke, S., D. Trick, K. Kamino, et al. 2005. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the [NZB x NZW]F1 mouse. Arthritis Rheum 52: 3629-3638
81. Chen, Y., S. Khanna, C. S. Goodyear, et al. 2009. Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis. J. Immunol 183: 1346-1359
82. Witte, T., K. Hartung, C. Sachse, et al. 1998. IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group. Rheumatol. Int 18: 85-91
83. Forger, F., T. Matthias, M. Oppermann, H. Becker, and K. Helmke. 2004. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 13: 36-44
84. Gronwall, C., E. Akhter, C. Oh, et al. IgM autoantibodies to distinct apoptosis-associated antigens correlate with protection from cardiovascular events and renal disease in patients with SLE. Clin. Immunol 142: 390-398
85. Su, J., X. Hua, H. Concha, et al. 2008. Natural antibodies against phosphorylcholine as potential protective factors in SLE. Rheumatology [Oxford] 47: 1144-1150
86. Li, Q. Z., C. Xie, T. Wu, et al. 2005. Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J. Clin. Invest 115: 3428-3439
87. Neeli, I., M. M. Richardson, S. N. Khan, et al. 2007. Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs. Mol. Immunol 44: 1914-1921
88. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med 179: 1317-1330
89. Cocca, B. A., A. M. Cline, and M. Z. Radic. 2002. Blebs and apoptotic bodies are B cell autoantigens. J. Immunol 169: 159-166
90. Kalaaji, M., K. A. Fenton, E. S. Mortensen, et al. 2007. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 71: 664-672
91. Botto, M., C. Dell'Agnola, A. E. Bygrave, et al. 1998. HomozygousC1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet 19: 56-59
92. Taylor, P. R., A. Carugati, V. A. Fadok, et al. 2000. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med 192: 359-366
93. Gommerman, J. L., and M. C. Carroll. 2000. Negative selection of B lymphocytes: a novel role for innate immunity. Immunol. Rev 173: 120-130
94. Scott, R. S., E. J. McMahon, S. M. Pop, et al. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207-211
95. Cline, A. M., and M. Z. Radic. 2004. Murine lupus autoantibodies identify distinct subsets of apoptotic bodies. Autoimmunity 37: 85-93
96. Cline, A. M., and M. Z. Radic. 2004. Apoptosis, subcellular particles, and autoimmunity. Clin. Immunol 112: 175-182
97. Radic, M., T. Marion, and M. Monestier. 2004. Nucleosomes are exposed at the cell surface in apoptosis. J. Immunol 172: 6692-6700
98. Quartier, P., P. K. Potter, M. R. Ehrenstein, M. J. Walport, and M. Botto. 2005. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol 35: 252-260
99. Kim, S. J., D. Gershov, X. Ma, N. Brot, and K. B. Elkon. 2002. I-PLA[2] activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196: 655-665
100. Ogden, C. A., R. Kowalewski, Y. Peng, V. Montenegro, and K. B. Elkon. 2005. IGM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 38: 259-264
101. Notley, C. A., M. A. Brown, G. P. Wright, and M. R. Ehrenstein. 2011. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol 186: 4967-4972
102. Chen, Y., Y. B. Park, E. Patel, andG. J. Silverman. 2009. IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J. Immunol 182: 6031-6043
103. Melero, J., D. Tarrago, A. Nunez-Roldan, and B. Sanchez. 1997. Human polyreactive IgM monoclonal antibodies with blocking activity against self-reactive IgG. Scand. J. Immunol 45: 393-400
104. R. C. Williams, Jr, C. C. Malone, G. R. Huffman, et al. 1995. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype [anti-F[ab']2] system. J. Rheumatol 22: 1075-1085
105. Rossi, F., G. Dietrich, and M. D. Kazatchkine. 1989. Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses. Immunol. Rev 110: 135-149
106. Lanzavecchia, A. 1985. Antigen-specific interactions between Tand B cells. Nature 314: 537
107. Joao, C., B. M. Ogle, C. Gay-Rabinstein, J. L. Platt, and M. Cascalho. 2004. B cell-dependent TCR diversification. J. Immunol 172: 4709-4716
108. Tumanov, A. V., S. I. Grivennikov, A. N. Shakhov, et al. 2003. Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev 195: 106-116
109. Harris, D. P., L. Haynes, P. C. Sayles, et al. 2000. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat. Immunol 1: 475-482
110. Lund, F. E. 2008. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol 20: 332-338
111. Eynon, E. E., andD. C. Parker. 1992. Small B cells as antigen presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med 175: 131
112. Melo,M. E., J. Qian, M. El-Amine, et al. 2002. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol 168: 4788-4795
113. Dalai, S. K., S. Mirshahidi, A. Morrot, F. Zavala, and S. Sadegh-Nasseri. 2008. Anergy in memory CD4 T cells is induced by B cells. J. Immunol 181: 3221-3231
114. Frommer, F., T. J. Heinen, F. T. Wunderlich, et al. 2008. Tolerance without clonal expansion: selfantigen-expressing B cells program self-reactive T cells for future deletion. J. Immunol 181: 5748-5759
115. Notkins, A. L. 2000. Polyreactive antibodies and polyreactive antigen-binding B [PAB] Cells. Curr. Top. Microbiol. Immunol 252: 241-249
116. Mizoguchi, A., and A. K. Bhan. 2006. A case for regulatory B cells. J Immunol 176: 705-710
117. Mauri, C., and M. R. Ehrenstein. 2008. The 'short' history of regulatory B cells. Trends Immunol 29: 34-40
118. Fillatreau, S., D. Gray, and S. M. Anderton. 2008. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat. Rev. Immunol 8: 391-397
119. Bouaziz, J. D., K. Yanaba, and T. F. Tedder. 2008. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol. Rev 224: 201-214
120. Jamin, C., A. Morva, S. Lemoine, et al. 2008. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum 58: 1900-1906
121. Blair, P. A., L. Y. Norena, F. Flores-Borja, et al. CD19[]-CD24[hi] CD38[hi] B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 32: 129-140
122. Wolf, S.D.,B.N.Dittel, F.Hardardottir, and C. A. Janeway, Jr. 1996. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J. Exp. Med 184: 2271-2278
123. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol 3: 944-950
124. Mizoguchi, A., E. Mizoguchi, R. N. Smith, F. I. Preffer, and A. K. Bhan. 1997. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J. Exp. Med 186: 1749-1756
125. Wei, B., P. Velazquez, O. Turovskaya, et al. 2005. Mesenteric B cells centrally inhibit CD4 T cell colitis through interaction with regulatory T cell subsets. Proc. Natl. Acad. Sci. USA 102: 2010-2015
126. Mauri, C., D. Gray, N. Mushtaq, and M. Londei. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med 197: 489-501
127. Evans, J. G., K. A. Chavez-Rueda, A. Eddaoudi, et al. 2007. Novel suppressive function of transitional 2 B cells in experimental arthritis. J. Immunol 178: 7868-7878
128. Hussain, S., and T. L. Delovitch. 2007. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner. J. Immunol 179: 7225-7232
129. Blair, P. A., K. A. Chavez-Rueda, J. G. Evans, et al. 2009. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J. Immunol 182: 3492-3502
130. Ho, A. S., and K. W. Moore. 1994. Interleukin-10 and its receptor. Ther. Immunol 1: 173-185
131. Tian, J., D. Zekzer, L. Hanssen, et al. 2001. Lipopolysaccharide- activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J. Immunol 167: 1081-1089
132. Lampropoulou, V., K. Hoehlig, T. Roch, et al. 2008. TLRactivated B cells suppress T cell-mediated autoimmunity. J. Immunol 180: 4763-4773
133. Brummel, R., and P. Lenert. 2005. Activation of marginal zone B cells from lupus mice with type A[D] CpGoligodeoxynucleotides. J. Immunol 174: 2429-2434
134. Leadbetter, E., I. Rifkin, A. Hohlbaum, et al. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607
135. Viglianti, G. A., C. M. Lau, T. M. Hanley, et al. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19: 837-847
136. Chen, X., and P. E. Jensen. 2007. Cutting edge: primary B lymphocytes preferentially expand allogeneic FoxP3 CD4 T cells. J. Immunol 179: 2046-2050
137. Kazatchkine, M. D., and S. V. Kaveri. 2001. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N. Engl. J. Med 345: 747-755
138. Jordan, S. C., M. Toyoda, and A. A. Vo. 2009. Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation 88: 1-6
139. Hurez, V.,M. D. Kazatchkine, T. Vassilev, et al. 1997. Pooled normal human polyspecific IgM contains neutralizing antiidiotypes to IgG autoantibodies of autoimmune patients and protects from experimental autoimmune disease. Blood 90: 4004-4013
140. Rieben, R., A. Roos, Y. Muizert, et al. 1999. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 93: 942-951
141. Zander, A. R., T. Zabelina, N. Kroger, et al. 1999. Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow. Bone Marrow Transplant 23: 889-893
142. Shoenfeld, Y., L. Rauova, B. Gilburd, et al. 2002. Efficacy of IVIG affinity-purified anti-double-stranded DNA antiidiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. Int. Immunol 14: 1303-1311